Scutellarin prevents obesity-induced renal fibrosis via reduced activation of AP-1
Abstract Background Renal fibrosis is characterized by the formation of scar tissue in the kidney parenchyma. Obesity, with its rising global incidence, has become a significant cause of renal fibrosis. This study investigates the effect of Scutellarin (SCU) on obesity-induced renal fibrosis. Method...
Saved in:
| Main Authors: | Haoan Yi, Yibing Jiang, Wei Li, Ling Shen, Wei Zhang, Shude Li, Yushan Xu, Fei Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06616-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current advances in the therapeutic potential of scutellarin: Novel applications, mechanisms, and future challenges
by: Great Iruoghene Edo, et al.
Published: (2025-05-01) -
Scutellarin: pharmacological effects and therapeutic mechanisms in chronic diseases
by: Shanshan Nie, et al.
Published: (2024-11-01) -
Recent advancement in the anticancer efficacy of the natural flavonoid scutellarin: a comprehensive review
by: Deena Elsori, et al.
Published: (2025-03-01) -
Scutellarin suppresses ovarian cancer progression by targeting METTL5
by: Ling Ding, et al.
Published: (2025-05-01) -
Scutellarin Alleviates Cuprizone-Induced Demyelination by Improving Mitochondrial Dysfunction, Reducing Lipid Oxidation and Inhibiting the p38 MAPK Pathway
by: Qiting Zhao, et al.
Published: (2025-06-01)